SALAROGLIO, Iris Chiara
SALAROGLIO, Iris Chiara
ONCOLOGIA
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer
2023-01-01 Anobile, Dario P; Salaroglio, Iris C; Tabbò, Fabrizio; La Vecchia, Sofia; Akman, Muhlis; Napoli, Francesca; Bungaro, Maristella; Benso, Federica; Aldieri, Elisabetta; Bironzo, Paolo; Kopecka, Joanna; Passiglia, Francesco; Righi, Luisella; Novello, Silvia; Scagliotti, Giorgio V; Riganti, Chiara
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
2018-01-01 Riganti, Chiara***; Lingua, MARCELLO FRANCESCO; Salaroglio, IRIS CHIARA; Falcomatà, Chiara; Righi, Luisella; Morena, Deborah; Francesca, Picca; Oddo, Daniele; Kopecka, Joanna; Pradotto, Monica; Libener, Roberta; Orecchia, Sara; Bironzo, Paolo; Comunanza, Valentina; Bussolino, Federico; Novello, Silvia; Scagliotti, Giorgio Vittorio; DI NICOLANTONIO, Federica***; Taulli, Riccardo***; ***corresponding authors
Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma
2018-01-01 Salaroglio, Iris C; Mujumdar, Prashant; Annovazzi, Laura; Kopecka, Joanna; Mellai, Marta; Schiffer, Davide; Poulsen, Sally-Ann; Riganti, Chiara
Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells
2019-01-01 Riganti, Chiara; Contino, Marialessandra*; Guglielmo, Stefano; Perrone, Maria G.; Salaroglio, Iris C.; Milosevic, Vladan; Giampietro, Roberta; Leonetti, Francesco; Rolando, Barbara; Lazzarato, Loretta; Colabufo, Nicola A.; Fruttero, Roberta
Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs
2024-01-01 Bartkowski M.; Bincoletto V.; Salaroglio I.C.; Ceccone G.; Arenal R.; Nervo S.; Rolando B.; Riganti C.; Arpicco S.; Giordani S.
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
2019-01-01 Salaroglio I.C.; Mungo E.; Gazzano E.; Kopecka J.; Riganti C.
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition
2023-01-01 Teixeira, Ricardo G; Salaroglio, Iris C; Oliveira, Nuno F B; Sequeira, João G N; Fontrodona, Xavier; Romero, Isabel; Machuqueiro, Miguel; Tomaz, Ana Isabel; Garcia, M Helena; Riganti, Chiara; Valente, Andreia
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors
2018-01-01 Gazzano, Elena; Rolando, Barbara; Chegaev, Konstantin; Salaroglio, Iris C.; Kopecka, Joanna; Pedrini, Isabella; Saponara, Simona; Sorge, Matteo; Buondonno, Ilaria; Stella, Barbara; Marengo, Alessandro; Valoti, Massimo; Brancaccio, Mara; Fruttero, Roberta; Gasco, Alberto; Arpicco, Silvia; Riganti, Chiara
GIFC-2018 - BOOK OF ABSTRACTS
2018-01-01 muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k
Hypoxia as a driver of resistance to immunotherapy
2021-01-01 Kopecka J.; Salaroglio I.C.; Perez-Ruiz E.; Sarmento-Ribeiro A.B.; Saponara S.; De Las Rivas J.; Riganti C.
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons
2021-01-01 Akman, Muhlis; Belisario, Dimas Carolina; Salaroglio, Iris Chiara; Kopecka, Joanna; Donadelli, Massimo; De Smaele, Enrico; Riganti, Chiara
Impact of cancer metabolism on therapy resistance – Clinical implications
2021-01-01 Goncalves A.C.; Richiardone E.; Jorge J.; Polonia B.; Xavier C.P.R.; Salaroglio I.C.; Riganti C.; Vasconcelos M.H.; Corbet C.; Sarmento-Ribeiro A.B.
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
2018-01-01 Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma
2018-01-01 Kopecka Joanna, Salaroglio Iris Chiara, Righi Luisella, Libener Roberta, Orecchia Sara, Grosso Federica, Milosevic Vladan, Ananthanarayanan Preeta, Ricci Luisa, Capelletto Enrica, Pradotto Monica, Napoli Francesca, Di Maio Massimo, Novello Silvia, Rubinstein Menachem, Scagliotti Giorgio Vittorio, Riganti Chiara
Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution
2019-01-01 Muntoni, Elisabetta; Martina, Katia; Marini, Elisabetta; Giorgis, Marta; Lazzarato, Loretta; Salaroglio, Iris Chiara; Riganti, Chiara; Lanotte, Michele; Battaglia, Luigi
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
2016-01-01 Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
2020-01-01 Kopecka J, Gazzano E, Castella B, Salaroglio IC, Mungo E, Massaia M, Riganti C
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
2022-01-01 Salaroglio, Iris C; Belisario, Dimas Carolina; Akman, Muhlis; La Vecchia, Sofia; Godel, Martina; Anobile, Dario Pasquale; Ortone, Giacomo; Digiovanni, Sabrina; Fontana, Simona; Costamagna, Costanzo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara
Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells
2022-01-01 Elena PEIRA; Daniela Chirio; Simona Sapino; Konstantin CHEGAEV; Giulia Chindamo; IRIS CHIARA SALAROGLIO; Chiara Riganti; Marina GALLARATE
New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro
2018-01-01 Salaroglio, Iris Chiara; Gazzano, Elena; Kopecka, Joanna; Chegaev, Konstantin; Costamagna, Costanzo; Fruttero, Roberta; Guglielmo, Stefano*; Riganti, Chiara
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer | 2023 | Anobile, Dario P; Salaroglio, Iris C; Tabbò, Fabrizio; La Vecchia, Sofia; Akman, Muhlis; Napoli, Francesca; Bungaro, Maristella; Benso, Federica; Aldieri, Elisabetta; Bironzo, Paolo; Kopecka, Joanna; Passiglia, Francesco; Righi, Luisella; Novello, Silvia; Scagliotti, Giorgio V; Riganti, Chiara | |
| Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment | 2018 | Riganti, Chiara***; Lingua, MARCELLO FRANCESCO; Salaroglio, IRIS CHIARA; Falcomatà, Chiara; Righi, Luisella; Morena, Deborah; Francesca, Picca; Oddo, Daniele; Kopecka, Joanna; Pradotto, Monica; Libener, Roberta; Orecchia, Sara; Bironzo, Paolo; Comunanza, Valentina; Bussolino, Federico; Novello, Silvia; Scagliotti, Giorgio Vittorio; DI NICOLANTONIO, Federica***; Taulli, Riccardo***; ***corresponding authors | |
| Carbonic Anhydrase XII Inhibitors Overcome P-Glycoprotein-Mediated Resistance to Temozolomide in Glioblastoma | 2018 | Salaroglio, Iris C; Mujumdar, Prashant; Annovazzi, Laura; Kopecka, Joanna; Mellai, Marta; Schiffer, Davide; Poulsen, Sally-Ann; Riganti, Chiara | |
| Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells | 2019 | Riganti, Chiara; Contino, Marialessandra*; Guglielmo, Stefano; Perrone, Maria G.; Salaroglio, Iris C.; Milosevic, Vladan; Giampietro, Roberta; Leonetti, Francesco; Rolando, Barbara; Lazzarato, Loretta; Colabufo, Nicola A.; Fruttero, Roberta | |
| Enhancing pancreatic ductal adenocarcinoma (PDAC) therapy with targeted carbon nano-onion (CNO)-mediated delivery of gemcitabine (GEM)-derived prodrugs | 2024 | Bartkowski M.; Bincoletto V.; Salaroglio I.C.; Ceccone G.; Arenal R.; Nervo S.; Rolando B.; Riganti C.; Arpicco S.; Giordani S. | |
| ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer | 2019 | Salaroglio I.C.; Mungo E.; Gazzano E.; Kopecka J.; Riganti C. | |
| Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition | 2023 | Teixeira, Ricardo G; Salaroglio, Iris C; Oliveira, Nuno F B; Sequeira, João G N; Fontrodona, Xavier; Romero, Isabel; Machuqueiro, Miguel; Tomaz, Ana Isabel; Garcia, M Helena; Riganti, Chiara; Valente, Andreia | |
| Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors | 2018 | Gazzano, Elena; Rolando, Barbara; Chegaev, Konstantin; Salaroglio, Iris C.; Kopecka, Joanna; Pedrini, Isabella; Saponara, Simona; Sorge, Matteo; Buondonno, Ilaria; Stella, Barbara; Marengo, Alessandro; Valoti, Massimo; Brancaccio, Mara; Fruttero, Roberta; Gasco, Alberto; Arpicco, Silvia; Riganti, Chiara | |
| GIFC-2018 - BOOK OF ABSTRACTS | 2018 | muntoni e, battaglia l, marini e, giorgis m, lazzarato l, salaroglio ic, riganti c, martina k | |
| Hypoxia as a driver of resistance to immunotherapy | 2021 | Kopecka J.; Salaroglio I.C.; Perez-Ruiz E.; Sarmento-Ribeiro A.B.; Saponara S.; De Las Rivas J.; Riganti C. | |
| Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons | 2021 | Akman, Muhlis; Belisario, Dimas Carolina; Salaroglio, Iris Chiara; Kopecka, Joanna; Donadelli, Massimo; De Smaele, Enrico; Riganti, Chiara | |
| Impact of cancer metabolism on therapy resistance – Clinical implications | 2021 | Goncalves A.C.; Richiardone E.; Jorge J.; Polonia B.; Xavier C.P.R.; Salaroglio I.C.; Riganti C.; Vasconcelos M.H.; Corbet C.; Sarmento-Ribeiro A.B. | |
| Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer | 2018 | Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna | |
| Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma | 2018 | Kopecka Joanna, Salaroglio Iris Chiara, Righi Luisella, Libener Roberta, Orecchia Sara, Grosso Federica, Milosevic Vladan, Ananthanarayanan Preeta, Ricci Luisa, Capelletto Enrica, Pradotto Monica, Napoli Francesca, Di Maio Massimo, Novello Silvia, Rubinstein Menachem, Scagliotti Giorgio Vittorio, Riganti Chiara | |
| Methotrexate-Loaded Solid Lipid Nanoparticles: Protein Functionalization to Improve Brain Biodistribution | 2019 | Muntoni, Elisabetta; Martina, Katia; Marini, Elisabetta; Giorgis, Marta; Lazzarato, Loretta; Salaroglio, Iris Chiara; Riganti, Chiara; Lanotte, Michele; Battaglia, Luigi | |
| Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma | 2016 | Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara | |
| Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? | 2020 | Kopecka J, Gazzano E, Castella B, Salaroglio IC, Mungo E, Massaia M, Riganti C | |
| Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer | 2022 | Salaroglio, Iris C; Belisario, Dimas Carolina; Akman, Muhlis; La Vecchia, Sofia; Godel, Martina; Anobile, Dario Pasquale; Ortone, Giacomo; Digiovanni, Sabrina; Fontana, Simona; Costamagna, Costanzo; Rubinstein, Menachem; Kopecka, Joanna; Riganti, Chiara | |
| Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells | 2022 | Elena PEIRA; Daniela Chirio; Simona Sapino; Konstantin CHEGAEV; Giulia Chindamo; IRIS CHIARA SALAROGLIO; Chiara Riganti; Marina GALLARATE | |
| New tetrahydroisoquinoline derivatives overcome pgp activity in brain-blood barrier and glioblastoma multiforme in vitro | 2018 | Salaroglio, Iris Chiara; Gazzano, Elena; Kopecka, Joanna; Chegaev, Konstantin; Costamagna, Costanzo; Fruttero, Roberta; Guglielmo, Stefano*; Riganti, Chiara |